Business Board meeting

Genmab Appoints New Board Leadership

Analysis based on 10 articles · First reported Jan 29, 2026 · Last updated Mar 19, 2026

Sentiment

Attention

Articles

Market Impact

Direct

Live prominence charts, article sentiment distribution, and event development timeline available on the NewsDesk Dashboard

Market Impact

The market impact is likely positive for Genmab, as the appointment of new leadership and the granting of employee incentives can signal stability and future growth potential. This event is a routine corporate governance update, so the broader market impact is minimal.

Biotechnology Pharmaceuticals

Event Summary

Following its Annual General Meeting on March 19, 2026, Genmab's Board of Directors met and appointed Ms. Deirdre P. Connelly as Chair and Ms. Pernille Erenbjerg as Deputy Chair. Additionally, Genmab decided to grant 5,213 restricted stock units and 4,485 warrants to its employees and subsidiaries. These incentives are awarded cost-free, with restricted stock units having a fair value of DKK 1,645.00 per share and warrants having an exercise price of DKK 1,645.00 and a fair value of DKK 530.62. Both the restricted stock units and warrants will vest three years after the grant date, with warrants expiring on the seventh anniversary of the grant date.

Key Actions

90 Genmab appointed new Chair and Deputy Chair to its Board of Directors

80 Genmab granted restricted stock units to employees

80 Genmab granted warrants to employees

70 Deirdre P. Connelly appointed Chair of Genmab's Board of Directors Genmab

70 Pernille Erenbjerg appointed Deputy Chair of Genmab's Board of Directors Genmab

Entities Involved

stock

Genmab

Genmab's Board of Directors met and appointed a new Chair and Deputy Chair. The company also granted restricted stock units and warrants to its employees, which could incentivize performance and align employee interests with shareholder value.

Importance 100 Sentiment 10

per

Deirdre P. Connelly

Deirdre P. Connelly was appointed Chair of the Board of Directors for Genmab, indicating a leadership change at the top of the company's governance structure.

Importance 70 Sentiment 10

per

Pernille Erenbjerg

Pernille Erenbjerg was appointed Deputy Chair of the Board of Directors for Genmab, contributing to the new leadership team.

Importance 70 Sentiment 10

cnt

Denmark

Genmab is headquartered in Denmark, which is the location of the Annual General Meeting and subsequent Board of Directors meeting.

Importance 5 Sentiment 0

Relationships

Deirdre P. Connelly related ↔ Genmab

Pernille Erenbjerg related ↔ Genmab

Genmab related ↔ Denmark

Deirdre P. Connelly related ↔ Pernille Erenbjerg

NEWSDESK

Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard